Tafoxiparin, a new drug candidate (phase II B) for cervical and uterine priming at planned delivery
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA(2023)